Publications by authors named "Emmanuel Cormier"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

95,885

Total Likes

6,107

Extended Reach

2,426,225

Social Features

343
A
A Fast Path from Innovation to Safe and Effective Medicines.
Peter Arlett, Falk Ehmann, Ralf Herold, Evdokia Korakianiti, Pierpaolo Moscariello, Emmanuel Cormier

Clin Pharmacol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing pharmacogenomics in medicines regulation and clinical practice: a call for collaborative action.
Jasmine Gratton, Peter Arlett, Falk Ehmann, Daniel Prieto-Alhambra, Patrice Verpillat, Emmanuel Cormier

Nat Rev Drug Discov· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into Early Interactions on Innovative Developments with European Regulators.
David W Uster, Valentina Cordo', Emmanuel Cormier, Falk Ehmann

Ther Innov Regul Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.
Gloria Omosa-Manyonyi, Juliet Mpendo, Eugene Ruzagira, William Kilembe, Elwyn Chomba, Emmanuel Cormier

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.
Ling Yue, Katja J Pfafferott, Joshua Baalwa, Karen Conrod, Catherine C Dong, Emmanuel Cormier

PLoS Pathog· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses.
Marloes A Naarding, Natalia Fernandez, John C Kappes, Peter Hayes, Tina Ahmed, Emmanuel Cormier

J Immunol Methods· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlates.
Heather A Prentice, Matthew A Price, Travis R Porter, Emmanuel Cormier, Michael J Mugavero

Virology· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.
Pauli N Amornkul, Etienne Karita, Anatoli Kamali, Wasima N Rida, Eduard J Sanders, Emmanuel Cormier

AIDS· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-B*57 versus HLA-B*81 in HIV-1 infection: slow and steady wins the race?
Heather A Prentice, Travis R Porter, Matthew A Price, Emmanuel Cormier, Dongning He

J Virol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.
Michael C Keefer, Jill Gilmour, Peter Hayes, Dilbinder Gill, Jakub Kopycinski, Emmanuel Cormier

PLoS One· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones.
Joshua Baalwa, Shuyi Wang, Nicholas F Parrish, Julie M Decker, Brandon F Keele, Emmanuel Cormier

Virology· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
Megan K Murphy, Ling Yue, Ruimin Pan, Saikat Boliar, Anurag Sethi, Emmanuel Cormier

PLoS Pathog· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes.
Jianming Tang, Emmanuel Cormier, Jill Gilmour, Matthew A Price, Heather A Prentice

J Virol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors.
Hiroto Hara, Hiroto Hara, Takashi Hironaka, Makoto Inoue, Akihiro Iida, Emmanuel Cormier

Hum Vaccin· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus.
Laurent Meertens, Claire Bertaux, Lisa Cukierman, Emmanuel Cormier, Dimitri Lavillette

J Virol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions.
Claire Bertaux, Dirk Daelemans, Laurent Meertens, Emmanuel G Cormier, John F Reinus

Virology· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticles.
Emilia Falkowska, Robert J Durso, Jason P Gardner, Emmanuel G Cormier, Robert A Arrigale

J Gen Virol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.
Emmanuel G Cormier, Robert J Durso, Fotini Tsamis, Lise Boussemart, Catherine Manix

Proc Natl Acad Sci U S A· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD81 is an entry coreceptor for hepatitis C virus.
Emmanuel G Cormier, Fay Tsamis, Francis Kajumo, Robert J Durso, Jason P Gardner

Proc Natl Acad Sci U S A· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1.
Julie Dumonceaux, Emmanuel G Cormier, Francis Kajumo, Gerald P Donovan, Jayanta Roy-Chowdhury

J Virol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor.
Emmanuel G Cormier, Tatjana Dragic

J Virol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates.
Daniah A D Thompson, Emmanuel G Cormier, Tatjana Dragic

J Virol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis